| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Pennsylvania |
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000189 |
Purpose
The purpose of this study is to test antidepressant medication, gepirone, as a pharmacotherapy for cocaine dependent subjects.
| Condition | Intervention | Phase |
|
Cocaine-Related Disorders |
Drug: Gepirone |
Phase II |
| Drug Information available for: | 8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))- Cocaine hydrochloride Gepirone |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Gepirone Vs Placebo in Treatment of Cocaine Dependence |
Eligibility
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, Pennsylvania | |||||
| University of Pennsylvania | |||||
| Philadelphia, Pennsylvania, United States, 19104 6178 | |||||
| National Institute on Drug Abuse (NIDA) |
| University of Pennsylvania |
| Principal Investigator: | James Cornish, M.D. | University of Pennsylvania |
More Information
| Study ID Numbers: | NIDA-00144-3, K20-00144-3 |
| First Received: | September 20, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000189 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
